Yearly 160 BW of pharmaceutical business losses under FTA.

It is estimated for the local pharmaceutical industry to face about 90.4 to 168.8 billion won of annual pharmaceutical sales losses for 10 years under the KORUS FTA according to "Analysis of KORUS FTA economic effects" released on April 30 by 11 national research institutes including the government and the overseas economic policy institute.

The detailed annual sales losses in the pharmac...